Model
Edge
Lineage Cell Therapeutics
0001325697
Filing Type
4
Filing Date
7/5/2022
Updated
7/6/22, 10:15 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership